J, P. S., K, S., I, K., J, H., A, M. P., M, P., . . . WS, W. (2024). Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies. Frontiers in immunology, 15, 1457887. https://doi.org/10.3389/fimmu.2024.1457887
Chicago Style (17th ed.) CitationJ, Pfeifer Serrahima, et al. "Bispecific Killer Cell Engagers Employing Species Cross-reactive NKG2D Binders Redirect Human and Murine Lymphocytes to ErbB2/HER2-positive Malignancies." Frontiers in Immunology 15 (2024): 1457887. https://doi.org/10.3389/fimmu.2024.1457887.
MLA (9th ed.) CitationJ, Pfeifer Serrahima, et al. "Bispecific Killer Cell Engagers Employing Species Cross-reactive NKG2D Binders Redirect Human and Murine Lymphocytes to ErbB2/HER2-positive Malignancies." Frontiers in Immunology, vol. 15, 2024, p. 1457887, https://doi.org/10.3389/fimmu.2024.1457887.